Background: Human bocavirus (HBoV) 1 can cause life-threatening respiratory tract infection in children. Diagnosing acute HBoV1 infection is challenging owing to long-term airway persistence. We assessed whether messenger RNA (mRNA) detection would correlate better than DNA detection with acute HBoV1 infection. Methods: Paired serum samples from 121 children with acute wheezing were analyzed by means of serology. Quantitative polymerase chain reaction (PCR) and reverse-transcription (RT) PCR were applied to nasopharyngeal swab (NPS) samples from all acutely HBoV1-infected children and from controls with nonacute infection. Results: By serology, 16 of 121 children (13.2%) had acute HBoV1 infection, all of whom had HBoV1 DNA in NPS samples, and 12 of 16 (75%) had HBoV1 mRNA. Among 25 children with nondiagnostic results, 6 had HBoV1 DNA in NPS samples, and 1 had mRNA. All 13 mRNA-positive samples exhibited high DNA loads (≥106 copies/mL). No mRNA persisted for 2 weeks, whereas HBoV1 DNA persisted for 2 months in 4 children; 1 year later all 15 samples were DNA negative. Compared with serology, DNA PCR had high clinical sensitivity (100%) but, because of viral persistence, low specificity (76%). In contrast, mRNA RT-PCR had low clinical sensitivity (75%) but high specificity (96%). Conclusions: A combination of HBoV1 serology and nasopharyngeal DNA quantitative PCR and mRNA RT-PCR should be used for accurate diagnosis of HBoV1 infection.
Background: Human bocavirus (HBoV) 1 can cause life-threatening respiratory tract infection in children. Diagnosing acute HBoV1 infection is challenging owing to long-term airway persistence. We assessed whether messenger RNA (mRNA) detection would correlate better than DNA detection with acute HBoV1 infection. Methods: Paired serum samples from 121 children with acute wheezing were analyzed by means of serology. Quantitative polymerase chain reaction (PCR) and reverse-transcription (RT) PCR were applied to nasopharyngeal swab (NPS) samples from all acutely HBoV1-infected children and from controls with nonacute infection. Results: By serology, 16 of 121 children (13.2%) had acute HBoV1 infection, all of whom had HBoV1 DNA in NPS samples, and 12 of 16 (75%) had HBoV1 mRNA. Among 25 children with nondiagnostic results, 6 had HBoV1 DNA in NPS samples, and 1 had mRNA. All 13 mRNA-positive samples exhibited high DNA loads (≥106 copies/mL). No mRNA persisted for 2 weeks, whereas HBoV1 DNA persisted for 2 months in 4 children; 1 year later all 15 samples were DNA negative. Compared with serology, DNA PCR had high clinical sensitivity (100%) but, because of viral persistence, low specificity (76%). In contrast, mRNA RT-PCR had low clinical sensitivity (75%) but high specificity (96%). Conclusions: A combination of HBoV1 serology and nasopharyngeal DNA quantitative PCR and mRNA RT-PCR should be used for accurate diagnosis of HBoV1 infection.
Authors: Joel J Credle; Matthew L Robinson; Jonathan Gunn; Daniel Monaco; Brandon Sie; Alexandra Tchir; Justin Hardick; Xuwen Zheng; Kathryn Shaw-Saliba; Richard E Rothman; Susan H Eshleman; Andrew Pekosz; Kasper Hansen; Heba Mostafa; Martin Steinegger; H Benjamin Larman Journal: bioRxiv Date: 2020-06-03
Authors: Zaiga Nora-Krukle; Anda Vilmane; Man Xu; Santa Rasa; Inga Ziemele; Elina Silina; Maria Söderlund-Venermo; Dace Gardovska; Modra Murovska Journal: Viruses Date: 2018-11-15 Impact factor: 5.048
Authors: Philipp P Nelson; Barbara A Rath; Paraskevi C Fragkou; Emmanouil Antalis; Sotirios Tsiodras; Chrysanthi Skevaki Journal: Front Cell Infect Microbiol Date: 2020-04-29 Impact factor: 5.293
Authors: Amanda C Nascimento-Carvalho; Ana-Luisa Vilas-Boas; Maria-Socorro H Fontoura; Man Xu; Tytti Vuorinen; Maria Söderlund-Venermo; Olli Ruuskanen; Cristiana M Nascimento-Carvalho Journal: Pediatr Pulmonol Date: 2017-10-13
Authors: Nicola Isabelle Kols; Heli Aatola; Ville Peltola; Man Xu; Zaiga Nora-Krukle; Klaus Hedman; Aurelija Zvirbliene; Hanna Toivola; Tytti Vuorinen; Juha M Koskinen; Andrea H L Bruning; Andreas Christensen; Maria Söderlund-Venermo; Janne O Koskinen Journal: J Clin Virol Date: 2019-09-04 Impact factor: 3.168